Rockefeller Capital Management L.P. Reata Pharmaceuticals Inc Transaction History

Rockefeller Capital Management L.P.

  • $36.3 Billion
  • Q3 2024

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
BUY
$79.22 - $105.37 $4,753 - $6,322
60 Added 0.93%
6,534 $666,000
Q4 2022

Mar 06, 2023
BUY
$22.15 - $42.11 $21,042 - $40,004
950 Added 17.2%
6,474 $245,000
Q3 2022

Nov 02, 2022
SELL
$19.41 - $36.49 $14,906 - $28,024
-768 Reduced 12.21%
5,524 $138,000
Q2 2022

Aug 12, 2022
BUY
$20.71 - $36.5 $3,479 - $6,132
168 Added 2.74%
6,292 $191,000
Q1 2022

May 13, 2022
BUY
$24.12 - $39.6 $117,560 - $193,010
4,874 Added 389.92%
6,124 $200,000
Q4 2021

Feb 14, 2022
SELL
$25.61 - $110.96 $56,060 - $242,891
-2,189 Reduced 63.65%
1,250 $32,000
Q3 2021

Nov 12, 2021
SELL
$100.0 - $143.02 $96,900 - $138,586
-969 Reduced 21.98%
3,439 $345,000
Q2 2021

Aug 10, 2021
BUY
$78.27 - $151.29 $211,955 - $409,693
2,708 Added 159.29%
4,408 $623,000
Q4 2020

Feb 12, 2021
SELL
$102.03 - $184.62 $4,387 - $7,938
-43 Reduced 2.47%
1,700 $210,000
Q3 2020

Nov 13, 2020
BUY
$93.53 - $163.34 $160,684 - $280,618
1,718 Added 6872.0%
1,743 $169,000
Q2 2020

Aug 12, 2020
SELL
$126.3 - $176.56 $2,020 - $2,824
-16 Reduced 39.02%
25 $4,000
Q1 2020

May 12, 2020
SELL
$124.16 - $247.74 $1,117 - $2,229
-9 Reduced 18.0%
41 $6,000
Q3 2019

Nov 12, 2019
BUY
$71.26 - $95.75 $3,563 - $4,787
50 New
50 $4,000

Others Institutions Holding RETA

# of Institutions
5
Shares Held
62.7K
Call Options Held
0
Put Options Held
0
View Full List

About REATA PHARMACEUTICALS INC

RETA Quotes by TradingView
  • Ticker RETA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,583,200
  • Description
  • Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...
More about RETA
Track This Portfolio

Track Rockefeller Capital Management L.P. Portfolio

Follow Rockefeller Capital Management L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

News

Stay updated on Rockefeller Capital Management L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email